Antiarrythmics (Cardio and Renal 2) Flashcards
4 classes of Antiarrhythmics
- Na+ Channels Blockers
- Beta Blockers
- K+ Channels Blockers
- Calcium channel Blocker
1 & 3 - big guns for life threatening situations
2 and 4 - toy guns
Antiarrhythmics: Miscellaneous Drugs
Adenosine
Digoxin
Magnesium Sulfate
Heart Action Potentials - Phase 0
Depolarization
Increase Na+ current
Heart Action Potentials - Phase 1
Overshoot
Initial repolarization inactivation of Na+ channel
Decrease K+
Heart Action Potentials - Phase 2
Plateau
Increase Ca2+
Decrease K+ currents
Heart Action Potentials - Phase 3
Repolarization
Decrease K+ current
Heart Action Potentials - Phase 4
Resting potential
Maintained by Na+/K+ ATPase Pump
Electrophysiological Properties of the Heart (1 of 4) - Responsiveness
Capacity of a cell to depolarize
Depends on the # of Na+ channels in ready state
Electrophysiological Properties of the Heart (2 of 4) - Conductance
Rate of spread of an impulse (conduction velocity)
Depends on: Vmax, Threshold potential, and resting membrane potential
Electrophysiological Properties of the Heart (3 of 4) - Automaticity
Ability to spontaneously depolarize
Electrophysiological Properties of the Heart (4 of 4) - Refractoriness (Refractory HTN)
Inability to respond to a stimulus
Electrophysiological Properties of the Heart - Refractoriness
Effective Refractory Period (ERP) - Period during which no stimulus of any size will produce a response (Arrhythmia: Decrease ERP -> formation of premature impulse)
Relative Refractory Period (RRP) - a STRONG impulse may elicit a response
Measuring Refractory: ERP / Action Potential Duration (APD)
Decreased ERP –> Formation of premature impulses
The sodium channel exists in 3 states
- Resting or ready state
- Open or active state
- Inactivated or refractory state
The sodium channel is a voltage channel with 2 gates:
- M (activating)
2. h (inactivating) gate
Mechanism of Arrhythmia Formation: Abnormalities in impulse Formation
SA Node: Increase symp –> Tach
SA Node: increase parasym –> brady
Purkinje fibers
Mechanism of Arrhythmia Formation: Abnormalities in impulse Conduction (2)
Ectopic foci
Re-entry mechanisms
Mechanism of Arrhythmia Formation: Conduction block (A-V block) - 3 types
1st Degree - prolonged PR Interval (> .20 sec)
2nd Degree:
Mobitz I - Above AV node = intermittent failure of AV conduction
*PR lengthens before beat is dropped
Mobitz II - Unpredictable loss of AV conduction * Constant PR interval, but beats are dropped
3rd Degree - Failure of any impulses to be conducted from atria to ventricles
* Atria and Ventricle beat independently of each other (all over the place)
Na+ channel Blockers Class 1A
Quinidine, Procainamide, and Disopyramide
Activated Na+ channel
Decrease Vmax, and prolong APD (Action Potential Duration)
- Slowing rate of AP, prolong AP, and increasing ventricular ERP
Na+ channel Blockers 1A: Quinidine
*Increase APD and ERP in atria, ventricles, and purkinje fibers of His –> Phase 0 Shortened
Anticholinergic effect: Increase heart rate and conduction
Alpha blocking effect: vasodilation and reflex tachycardia
Na+ channel Blockers 1A: **Quinidine Side Effects
GI: NVD
CV: Increase QT interval (Torsades de Pointes)
Thrombocytopenia
**Cinchonism: tinnitus, loss of hearing, GI upset, diplopia
Na+ channel Blockers 1A: Quinidine Drug Interactions
Antacids increase quinidine absorption
***Displaces digoxin from tissue binding sites
Decrease Vd
Na+ channel Blockers 1A: Procainamide
Less anticholinergic
No alpha blocking activity
Active metabolite NAPA –> Prolongs the duration of AP and little effect on max polarization of Purkinje Fibers
Na+ channel Blockers 1A: Procainamide Side Effects
Agranulocytosis (Order CBC if pt. comes in with cough with any med causing agranulocytosis)
SLE like syndrome
Na+ channel Blockers 1A: Disopyramide
The most anticholinergic –> *Greater anti-ionotropic effect
Na+ Channel Blockers: 1B MOA and Uses
Inactivated Na+ channel
No effect on Vmax, but decrease APD
Uses:
Preference for ischemic tissues (partially depolarized)
Increase threshold of VFib
Slow conduction in hypoxic and ischemic tissue
Na+ Channel Blockers: 1B Drugs (3)
Lidocaine
Tocainide
Mexiletine
Na+ Channel Blockers 1B: Lidocaine (3)
- Rx: V-Tac after MI, or digitalis toxicity
- Least cardiotoxic
- Shortens Phase 3 repols and decreases APD
Na+ Channel Blockers 1B: Mexiletine and Tocainide
Given orally
Pulmonary toxicity (Pulmonar fibrosis)
Na+ Channel Blockers Class 1C MOA
Both Na+ Channels
Marked decrease of Vmax, but no effect on APD
Na+ Channel Blockers Class 1C: Drugs
Flecainide, Propafenone, Moricizine
Pro-arrhythmic effects: can worsen existing arrhythmia
Increase in sudden death and cardiac arrest after MI
Class 2: Beta Blockers Drugs (4)
Propanolol
Acebutalol
Esmolol: half life of 8 minutes; given IV for emergency in SVT
Metoprolol
Class 2: Beta Blockers MOA (3)
Decrease SA and AV nodal conduction
Decrease the slope of phase 4 depolarization
Used as prophylaxis Post-MI and to rx SVTs
Class 3: K+ Channel Blockers MOA
Increase APD and ERP
Prolong repolarization and lengthen phase 2 (prolonging relaxation of heart)
Class 3: K+ Channel Blockers Drugs (5)
Amiodarone
Ibutilide
Dofetilide
Dronaderone
Sotalol
Class 3: K+ Channel Blockers - Ibutilide and Dofetilide MOA (3)
Selectively block outward potassium channel called *delayed rectifier potassium channels
Prolong ventricular repolarization and increase the QT interval
Used for pharmacological cardioversion of atrial fibrillation and flutter
Class 3: K+ Channel Blockers: Amiodarone MOA (5)
Mimics class 1, 2, 3, and 4
Binds to Na+ channel (inactivated)
Blocks K+ and Ca2+ channels
Non-competitive inhibitor of B receptors
*Half-life: 25-60 days
Class 3: K+ Channel Blockers: Amiodarone Side Effects (5)
- Pulmonary fibrosis
- Hepatotoxicity
- Smurf skin (Bluish pigmentation of skin)
- Hypothyroidism 5% & hyperthyroidism 2%
- May cause torsades de pointes
Class 3: K+ Channel Blockers: Sotalol MOA (4)
*Beta blockers & K+ channel blockers
Class 2: Decrease heart rate and AV conduction
Class 3: Prolongs APD and ERP
*Rx of life threatening V arrhythmia
Class 3: K+ Channel Blockers: **Sotalol Side Effects
Headache, depression, and impotence
**Careful with asthmatic
Class 4: Calcium channel blockers MOA
Decrease SA and AV nodal conduction
Decrease slope of phase 4
Class 4: Calcium channel blockers: Drugs
Verapamil
Diltiazem
Rx: PSVT due to AV nodal re-entry
*Contraindicated in atrial tachycardia due to WPW (tissue problem)
Unclassified Anti-arrythmics: Adenosine MOA
Vasodilatation causing bradycardia –> reflex tachycardia
Rx of PSVT
Antagonist: Theophylline
Torsades de Pointes
Management
Discontinue the drug prolonging the QT
K+ channel blockers, thioridazine, TCAs
Correct hypokalemia and hypomagnesemia
Magnesium is indicated